Acadian Asset Management
ACIU icon

Acadian Asset Management’s AC Immune ACIU Stock Holding History

Acadian Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-96,907
Closed -$266K – 1973
2026
Q1 		$266K Sell
96,907
-367,790
-79% -$1.14M ﹤0.01% 1509
2025
Q4 		$1.44M Buy
464,697
+51,460
+12% +$162K ﹤0.01% 1012
2025
Q3 		$1.18M Buy
413,237
+1,541
+0.4% +$3.48K ﹤0.01% 1016
2025
Q2 		$820K Buy
411,696
+40,519
+11% +$70.5K ﹤0.01% 1018
2025
Q1 		$679K Buy
371,177
+172,796
+87% +$435K ﹤0.01% 1011
2024
Q4 		$528K Buy
198,381
+152,369
+331% +$476K ﹤0.01% 1063
2024
Q3 		$172K Buy
+46,012
New +$161K ﹤0.01% 1414
2023
Q2 		– Sell
-3,845
Closed -$8K – 1701
2023
Q1 		$8K Buy
+3,845
New +$8.9K ﹤0.01% 1692
2021
Q4 		– Sell
-107,093
Closed -$717K – 1653
2021
Q3 		$717K Sell
107,093
-117,398
-52% -$840K ﹤0.01% 944
2021
Q2 		$1.78M Sell
224,491
-51,929
-19% -$359K 0.01% 746
2021
Q1 		$2.1M Sell
276,420
-386,092
-58% -$2.76M 0.01% 717
2020
Q4 		$3.42M Sell
662,512
-191,368
-22% -$977K 0.01% 605
2020
Q3 		$4.17M Buy
853,880
+84,828
+11% +$609K 0.02% 482
2020
Q2 		$5.18M Buy
769,052
+21,271
+3% +$155K 0.02% 479
2020
Q1 		$5.16M Buy
747,781
+426,542
+133% +$3.33M 0.03% 393
2019
Q4 		$2.74M Buy
321,239
+173,555
+118% +$1.16M 0.01% 586
2019
Q3 		$729K Buy
147,684
+59,191
+67% +$317K ﹤0.01% 985
2019
Q2 		$492K Buy
+88,493
New +$451K ﹤0.01% 1021

Other funds holding ACIU

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's ACIU Position: Q2 2026 in Review

Acadian Asset Management sold out of AC Immune (ACIU) in Q2 2026, closing a stake of 96,907 shares — an estimated $266K sold.

Acadian Asset Management first reported a position in ACIU in Q2 2019 and held it in 18 quarters. The position peaked at $5.18M in Q2 2020. 37 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Acadian Asset Management reported no remaining AC Immune position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 96,907 AC Immune shares in Q2 2026, an estimated $266K.
  • Acadian Asset Management first reported a position in AC Immune in Q2 2019 and held it in 18 quarters.
  • Acadian Asset Management's AC Immune position peaked at $5.18M in Q2 2020.
  • 37 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.